WO2023195955 - A FILM COATED TABLET COMPRISING SELEXİPAG AND ITS PREPARATION PROCESS

National phase entry is expected:
Publication Number WO/2023/195955
Publication Date 12.10.2023
International Application No. PCT/TR2023/050304
International Filing Date 30.03.2023
Title **
[English] A FILM COATED TABLET COMPRISING SELEXİPAG AND ITS PREPARATION PROCESS
[French] COMPRIMÉ REVÊTU D'UN FILM COMPRENANT DU SÉLEXİPAG ET SON PROCÉDÉ DE PRÉPARATION
Applicants **
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
Inventors
SUNEL, Fatih
ATAK, Fadime Bilgehan
PEHLIVAN AKALIN, Nur
TUNC, Guldeniz
Priority Data
2022/005275   05.04.2022   TR
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2041
EPO Filing, Examination, Granting9209
Japan Filing, Examination, Granting2109
South Korea Filing, Examination, Granting1984
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 20,083

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] The present invention relates to a film coated tablet comprising selexipag or crystalline polymorph thereof and at least one pharmaceutically acceptable excipient, wherein tablet comprising at least one filler and the tablet is free of mannitol. Furthermore, the tablet is obtained using wet granulation with geometric dilution method.[French] La présente invention concerne un comprimé pelliculé comprenant du sélexipag ou un polymorphe cristallin de celui-ci et au moins un excipient pharmaceutiquement acceptable, le comprimé comprenant au moins une charge et le comprimé étant exempt de mannitol. En outre, le comprimé est obtenu à l'aide d'une granulation par voie humide avec un procédé de dilution géométrique.

Rejoining the server...